##SAMPLE=<ID=NA12878_03,Gender=female,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
##PIPELINE=megSAP 0.1-742-ged8ba02
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	gnomAD_sub	ESP_sub	gnomAD	phyloP	PolyPhen	Sift	OMIM	fathmm-MKL	CADD	REVEL	ClinVar	HGMD	COSMIC	NGSD_hom	NGSD_het	classification	classification_comment	validation	gene_info
chr2	215595164	215595164	G	A	het	pred_pathogenic_2	QUAL=334;DP=27;AF=0.44;MQM=60	BARD1	missense_variant,non_coding_exon_variant	BARD1:NM_000465.3:missense_variant:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense_variant:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense_variant:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense_variant:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense_variant:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon_variant:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon_variant:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079,0.0123	0.0079,0.0123	0.0078	5.1650	T	D,D,D,D	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];				RCV000130975.3 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	0	12			n/a (1xTP, 0xFP)	NOC2L (inh=n/a pLI=0.00)
chr3	142188337	142188337	A	C	het	pred_pathogenic_1	QUAL=11942;DP=680;AF=0.56;MQM=60	ATR	missense_variant	ATR:NM_001184.3:missense_variant:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.002	0.0033	0.0033	0.0069	2.3460	T	T,D	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];				RCV000145327.1 [uncertain significance]; 			0	17				ISG15 (inh=AR pLI=0.01)
chr5	131925483	131925483	G	C	het		QUAL=1006;DP=67;AF=0.49;MQM=60	RAD50	missense_variant	RAD50:NM_005732.3:missense_variant:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala		rs55653181	0.0002	0.0001	0.0001	0	6.3310	T	T,T,T	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];							0	0				AGRN (inh=AR pLI=0.17)
chr14	45606387	45606387	A	G	het	pred_pathogenic_3	QUAL=743;DP=52;AF=0.48;MQM=60	FANCM,FKBP3	missense_variant,upstream_gene	FANCM:NM_020937.2:missense_variant:MODERATE:exon2/23:c.624A>G:p.Ile208Met,FKBP3:NM_002013.3:upstream_gene:MODIFIER::c.-74T>C:		rs45547534	0.0054	0.011	0.011	0.0151	0.1250	T	D,D,D							COSM3753963	0	20				AURKAIP1 (inh=n/a pLI=0.00)
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1724;DP=109;AF=0.49;MQM=60	SLX4	missense_variant	SLX4:NM_032444.2:missense_variant:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0.0001	0.0002	0.3390	T	T	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];					CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		0	1				TMEM88B (inh=n/a pLI=n/a)